Welcome to our dedicated page for 22Nd Century news (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22Nd Century stock.
News for 22nd Century Group, Inc. (Nasdaq: XXII) centers on its role in tobacco harm reduction, regulatory developments, capital structure actions and the commercialization of its VLN® reduced nicotine cigarette platform. Company announcements frequently highlight progress in expanding VLN® and partner VLN® distribution across additional U.S. states and retail chains, including launches with major convenience store operators and authorizations in a large majority of states.
Investors following XXII news will see updates on VLN® regulatory milestones, such as the original FDA Modified Risk Tobacco Product authorization, the filing of the VLN® MRTP renewal application, and the company’s public support for the FDA’s proposed Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products. Releases also discuss clinical research findings related to very low nicotine content cigarettes, including reductions in daily cigarette consumption and increased quit attempts among smokers using 95% reduced nicotine VLN® products.
Another recurring theme in 22nd Century’s news is financial and corporate developments. The company reports on balance sheet changes such as repayment and termination of senior secured debt, settlement of insurance claims related to prior facility incidents, and the use of non-dilutive cash proceeds as growth capital. News items also cover equity and preferred stock financings, at-the-market offering arrangements, and proposals for reverse stock splits and other shareholder approvals under Nasdaq Listing Rules.
In addition, XXII news includes corporate governance and investor relations events, such as participation in investor conferences, quarterly earnings webcasts, and shareholder letters reviewing strategic progress. For readers tracking the intersection of tobacco regulation, reduced nicotine technology and public company capital markets activity, the XXII news feed provides ongoing context on how 22nd Century is executing its harm reduction-focused strategy.
22nd Century Group (Nasdaq: XXII) has secured a $9.5 million cash settlement from insurers for business interruption claims related to the November 2022 Grass Valley incident. The settlement payment must be made within 45 days of the agreement's effective date.
The company, now debt-free, views this non-dilutive capital as crucial for growth rather than survival. CEO Larry Firestone emphasized that after addressing legacy issues over the past 22 months, the company is positioned to achieve profitability in 2026.
22nd Century Group specializes in tobacco harm reduction through its proprietary non-GMO reduced nicotine tobacco plants, which contain 95% less nicotine than traditional tobacco. Their flagship product, VLN® cigarette, is the only FDA-authorized low nicotine combustible cigarette in the United States.
22nd Century Group (Nasdaq: XXII) has announced a significant financial milestone by becoming debt-free after repaying its remaining $3.9 million senior secured debt following the completion of its Series A convertible preferred stock offering. The company has eliminated over $20 million in senior secured and subordinated debt under CEO Larry Firestone's leadership.
The financial restructuring has resulted in an approximate $9.1 million increase in adjusted pro forma net tangible book value ($1.05 per share). The company plans to utilize its capital to expand its very low nicotine tobacco leaf inventory in Q4 2025, with capacity to produce over 1 million cartons of VLN combustible products. The company's VLN® cigarettes, containing 95% less nicotine than traditional cigarettes, remain the only FDA-authorized low nicotine combustible cigarette in the United States.
22nd Century Group (Nasdaq: XXII), a tobacco products company focused on reducing smoking harms and nicotine addiction, has announced its participation in the upcoming HC Wainwright Conference. The company's leadership, including CEO Larry Firestone and CFO Dan Otto, will conduct investor meetings on September 9, 2025 at the Lotte New York Palace Hotel.
Interested investors can schedule meetings through their HC Wainwright representative or by contacting 22nd Century's Investor Relations directly.
22nd Century Group (Nasdaq: XXII) CEO Larry Firestone provided a comprehensive update on the company's VLN® reduced nicotine tobacco products and regulatory developments. The company announced two major partnerships with Smoker Friendly and Pinnacle for VLN® product distribution, with initial Pinnacle stocking orders shipped in August 2025.
The FDA's proposed Tobacco Product Standard for Nicotine Yield, expected by September 15, 2025, could mandate a 0.7mg/g maximum nicotine content. The company is expanding its VLN® product line to include 100mm cigarettes, international versions, and filtered cigars. Additionally, research is underway exploring potential links between their non-GMO low nicotine tobacco genetics and reduced levels of harmful TSNAs (Tobacco-Specific Nitrosamines).
22nd Century Group (Nasdaq: XXII), a tobacco products company focused on reducing smoking harms through nicotine addiction control, has announced its participation in the upcoming Emerging Growth Virtual Investor Conference.
CEO Larry Firestone and CFO Dan Otto will present on August 20, 2025 at 1:10 PM ET. Investors can register online to attend the virtual presentation and submit questions in advance. A replay will be available in the Events section of the company's IR website.
22nd Century Group (Nasdaq: XXII) reported Q2 2025 financial results, showing a revenue decline to $4.1 million from $6.0 million in Q1 2025. The company reported a net loss of $3.3 million and an Adjusted EBITDA loss of $2.6 million.
Key developments include expanded state authorizations for VLN® products (now in 44 states), partnership with Pinnacle for VLN® distribution in nearly 1,000 locations of a top-5 c-store chain, and debt reduction of $1.0 million to $3.8 million. The company's cigarette volumes increased to 594,000 cartons in Q2 2025 compared to 319,000 in Q1 2025.
The company is advancing its tobacco harm reduction strategy with its proprietary reduced nicotine content tobacco products, including development of a 100mm VLN® cigarette prototype targeting FDA submission in Q4 2025.
[ "Expanded state authorizations to 44 states for VLN® products", "Secured partnership with Pinnacle VLN® for distribution in nearly 1,000 top-5 c-store locations", "Increased cigarette carton volumes by 86% quarter-over-quarter to 594,000", "Reduced debt by $1.0 million to $3.8 million", "Advanced development of 100mm VLN® reduced nicotine cigarette prototype" ]22nd Century Group (Nasdaq: XXII) has scheduled its Second Quarter 2025 earnings conference call for August 14, 2025, at 8:00 AM ET. The company will release its financial results via press release at 6:00 AM ET the same day.
CEO Larry Firestone and CFO Dan Otto will lead the webcast, discussing quarterly results, recent developments, and outlook for 2025. The webcast will be available live and archived on the company's investor relations website.
22nd Century Group (Nasdaq: XXII) announced the initial shipments of its Pinnacle VLN® Gold and Pinnacle VLN® Menthol reduced nicotine cigarettes. The products will launch on September 1, 2025 across nearly 1,000 locations in 12 states through a top-5 U.S. convenience store chain.
The Pinnacle VLN® cigarettes contain 95% less nicotine compared to traditional cigarettes, meeting the FDA's proposed standard of less than 0.7 mg/g nicotine content. These products are the first and only FDA-authorized combusted cigarettes specifically designed to reduce nicotine intake, supported by extensive clinical research demonstrating their effectiveness in reducing smoking habits.
22nd Century Group (Nasdaq: XXII) welcomes the American Academy of Family Physicians' (AAFP) support for the FDA's proposed reduced nicotine mandate. The AAFP, representing over 128,300 family physicians, endorses establishing a maximum nicotine yield of 0.7 milligrams per gram of tobacco in combustible products.
The company's VLN® products, including partner brands Smoker Friendly VLN® and Pinnacle VLN®, are currently the only FDA-authorized reduced nicotine content cigarettes that comply with the proposed standard. According to the release, smoking causes over 480,000 deaths and costs more than $600 billion annually in the United States, while reducing life expectancy by 10 years.
22nd Century Group (Nasdaq: XXII) announced significant progress in state authorizations for its tobacco product portfolio. The company has secured approval to sell its VLN® reduced nicotine content cigarettes in up to 41 states, along with expanded authorizations for partner brands and conventional products.
The company's flagship VLN® products contain 95% less nicotine than conventional cigarettes and are the only combustible cigarettes that comply with the FDA's proposed Low Nicotine Mandate. 22nd Century has secured partnerships with retailers representing over 2,000 outlets for implementation in the second half of 2025.
The expanded state authorizations cover multiple product lines including VLN® Gold and Green (41 states), VLN® Red (21 states), Smoker Friendly VLN® (20 states), Pinnacle® VLN® (20 states), and various conventional products across different states.